FDA Inspection
Apitoria Pharma Private LimitedApitoria Pharma Private Limited – FDA Inspection, Oct 14, 2016
Record Details
This FDA Inspection record concerns Apitoria Pharma Private Limited, with an inspection on October 14, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · db5a1173-0ed5-4ae2-8f96-5c24cdb16431
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 996399
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Apitoria Pharma Private Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| December 12, 2025 | Not classified | Office of Inspections and Investigations | |
| December 17, 2024 | Not classified | Office of Inspections and Investigations | |
| March 3, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 13, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Apitoria Pharma Private Limited
- FDA Inspection 1297984 - 2025-12-12
- FDA Inspection 1257318 - 2024-12-17
- FDA Inspection 1245719 - 2023-03-03
- FDA Inspection 1109465 - 2019-10-28
- FDA Inspection 1067776 - 2018-07-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.